Patients' Knowledge of Key Messaging in Drug Safety Communications for Zolpidem and Eszopiclone: A National Survey.

MLA

Kesselheim, Aaron S., et al. “Patients’ Knowledge of Key Messaging in Drug Safety Communications for Zolpidem and Eszopiclone: A National Survey.” The Journal of Law, Medicine & Ethics : A Journal of the American Society of Law, Medicine & Ethics, vol. 47, no. 3, Sept. 2019, pp. 430–41. EBSCOhost, https://doi.org/10.1177/1073110519876176.

APA

Kesselheim, A. S., Sinha, M. S., Rausch, P., Lu, Z., Tessema, F. A., Lappin, B. M., Zhou, E. H., Dal Pan, G. J., Zwanziger, L., Ramanadham, A., Loughlin, A., Enger, C., Avorn, J., & Campbell, E. G. (2019). Patients’ Knowledge of Key Messaging in Drug Safety Communications for Zolpidem and Eszopiclone: A National Survey. The Journal of Law, Medicine & Ethics : A Journal of the American Society of Law, Medicine & Ethics, 47(3), 430–441. https://doi.org/10.1177/1073110519876176

Chicago

Kesselheim, Aaron S, Michael S Sinha, Paula Rausch, Zhigang Lu, Frazer A Tessema, Brian M Lappin, Esther H Zhou, et al. 2019. “Patients’ Knowledge of Key Messaging in Drug Safety Communications for Zolpidem and Eszopiclone: A National Survey.” The Journal of Law, Medicine & Ethics : A Journal of the American Society of Law, Medicine & Ethics 47 (3): 430–41. doi:10.1177/1073110519876176.